<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMM</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Medicine</journal-title></journal-title-group>
<issn pub-type="ppub">1107-3756</issn>
<issn pub-type="epub">1791-244X</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ijmm.2024.5382</article-id>
<article-id pub-id-type="publisher-id">ijmm-54-01-05382</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject></subj-group></article-categories>
<title-group>
<article-title>[Retracted] Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Zeng</surname><given-names>Zhou</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Gao</surname><given-names>Zhao-Lin</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname><given-names>Zhi-Pei</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Jiang</surname><given-names>Hai-Bo</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Yang</surname><given-names>Chang-Quan</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Yang</surname><given-names>Jie</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Xia</surname><given-names>Xiao-Bo</given-names></name></contrib></contrib-group>
<pub-date pub-type="collection">
<month>07</month>
<year>2024</year></pub-date>
<pub-date pub-type="epub">
<day>13</day>
<month>05</month>
<year>2024</year></pub-date>
<volume>54</volume>
<issue>1</issue>
<elocation-id>58</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x000A9; 2024 Zeng et al.</copyright-statement>
<copyright-year>2024</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license></permissions></article-meta></front>
<body>
<p>Int J Mol Med 44: <related-article id="RA1" related-article-type="retracted-article" vol="44" page="103" ext-link-type="doi" xlink:href="10.3892/ijmm.2019.4183">103-114</related-article>, 2019; DOI: 10.3892/ijmm.2019.4183</p>
<p>Following the publication of the above paper, it has been drawn to the Editors' attention by a concerned reader that certain of the lumen formation assay data shown in Fig. 5A on p. 112 were strikingly similar to data appearing in different form in another article written by different authors at different research institute, which had already been published in the journal <italic>Biomedicine &amp; Pharmacotherapy</italic> prior to the submission of this paper to <italic>International Journal of Molecular Medicine</italic>, and which has also subsequently been retracted. In view of the fact that the contentious data had already apparently been published previously, the Editor of <italic>International Journal of Molecular Medicine</italic> has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.</p></body></article>
